Hong Kong’s Ming Pao daily said in its editorial that there were grounds to believe that the UAE must have been stringent with the review and registration of the Chinese vaccine, given the country’s record of being transparent in its anti-virus policymaking and mass testing.
“The UAE also maintains sound ties with the West so sourcing vaccines from the United States or elsewhere should not be a grave challenge. If the Chinese vaccine is not safe or effective, there is no reason for the UAE to endorse Beijing’s vaccine propaganda and risk its own image and the health of its own people.
“Thus the UAE’s approval and its top leader’s injection of the SinoPharm vaccine have come as a much-needed vote of confidence that will help convince more countries. Diversified supply of vaccines, with viable alternatives from China, is key to ensuring fair and equitable access by poor countries,” said the op-ed.
SinoPharm revealed that senior officials in Egypt and Bahrain also took part in trials held there.
ku lari bukan sebab tak percaya surat MOSTI tapi pasal asyik PP, shares dah banyak, tambah, tambah and tambah lagi, seriau dah macam bunyi sumatec dulu, pendapat ku la kalau vaccine dah dapat approval KSTAR yang akan lompat2 naik, pasal senang sikit goreng. pendapat je, bukan buy or sell call ya
@Flyingwithwings I calculated the average private placement share price that is equivalent to 0.163. Hence if it closes at 0.160 tomorrow, it will not be a good sign.....
Found the official website of Sinopharm Group Hunan Changde Medical Co Ltd as follows but it is in Chinese. You can use google translate widget to view the webpage in English. The address stated is as follows and it matches the address stated in the COLLABORATION AGREEMENT WITH SINOPHARM GROUP HUNAN CHANGDE MEDICAL CO. LTD. document found in Bursa Malaysia website under Company Announcements :
No. 22, Longmei Street, Changde Economic and Technological Development Zone, Hunan Province (3rd Floor, Building 2, Area A, Small and Medium-sized Enterprise Park)
---------------------------- No. 22, 3rd Floor, Zone A, Tower 2, Long Mei Street, Changde Economic and Technological Development Changde, Hunan Province, PRC.
@NPRA, yes, have seen this earlier but good job sharing it with others. That was why I said the Kanger investor-relations fellas are not doing a good job. If investors need to hunt and seek for infos as basic as those in their fingertips, it means they dont respect funds keeping their salaries alive.
investors found it is like no better info can get from the forum except vaccine articles. is kanger a vaccine ctr? it is a waste of time to read or invest in kanger. correct?
if vaccine news cant move kanger share price. why still flooded the forum with vaccine articles. investors cant find better info will avoid this ctr. correct?
CAIRO, EGYPT receives first batch of Sinopharm coronavirus vaccines
CAIRO, Dec 10 (Reuters) - Egypt received its first shipment of vaccines developed by China National Pharmaceutical Group (Sinopharm) late on Thursday and will get more deliveries soon, health officials said.
The shipment arrived at Cairo airport from the United Arab Emirates, which has been carrying out phase III clinical trials of the vaccine.
The UAE health ministry said this week that the Sinopharm vaccine had 86% efficacy, citing an interim analysis of the late-stage clinical trials.
The vaccine has already been used on about 1 million people in China in an emergency programme.
In Egypt the vaccine, taken in two doses 21 days apart, will be free of charge and the government will prioritise vaccinating medical staff and people with chronic diseases, health officials said.
It was unclear how many doses of the vaccine Egypt had ordered, but the health minister said there would be more shipments in the days to come.
Egypt, with a population of more than 100 million, is a large market for vaccines. In September, Russia announced a deal to supply Egypt with 25 million doses of the Sputnik V vaccine.
Egypt's government has confirmed relatively low numbers of coronavirus infections, partly due to limited public testing, but has been warning of a second wave of the pandemic as daily infections have risen in recent weeks.
useless article cant even help the price to go up. post also no point. more investors will shun kanger forum as no better articles to read and hard to access. correctt?
msia not approved yet. the whole world approved is also useless. still cannot import china vaccine. whats the point floed those news in the forum. correct?
I believe Malaysia cannot wait for Pfizer Vaccine. So far ONLY Sinopharm had submitted for approval in China and UAE had registered for public use.
Malaysia broke the record for yet another new daily Covid-19 positive cases: 2,234! The previous high was 2,188 cases on 24/11. Worse, Selangor alone had 1,428 cases!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
NPRA1985
3,415 posts
Posted by NPRA1985 > 2020-12-10 22:18 | Report Abuse
Hong Kong’s Ming Pao daily said in its editorial that there were grounds to believe that the UAE must have been stringent with the review and registration of the Chinese vaccine, given the country’s record of being transparent in its anti-virus policymaking and mass testing.
“The UAE also maintains sound ties with the West so sourcing vaccines from the United States or elsewhere should not be a grave challenge. If the Chinese vaccine is not safe or effective, there is no reason for the UAE to endorse Beijing’s vaccine propaganda and risk its own image and the health of its own people.
“Thus the UAE’s approval and its top leader’s injection of the SinoPharm vaccine have come as a much-needed vote of confidence that will help convince more countries. Diversified supply of vaccines, with viable alternatives from China, is key to ensuring fair and equitable access by poor countries,” said the op-ed.
SinoPharm revealed that senior officials in Egypt and Bahrain also took part in trials held there.
https://asiatimes.com/2020/12/uae-gives-chinese-vaccines-a-shot-in-the-arm/